Filing Details
- Accession Number:
- 0001213900-20-037919
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-18 13:50:45
- Reporting Period:
- 2020-11-16
- Accepted Time:
- 2020-11-18 13:50:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1444307 | Oncosec Medical Inc | ONCS | Pharmaceutical Preparations (2834) | 980573252 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1755469 | Alpha Holdings, Inc. | Gangnam-Gu Apgujeong-Ro 62-Gil 17-10 Seoul M5 06016 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-11-16 | 40,000 | $5.41 | 1,571,000 | No | 4 | S | Indirect | By Alpha Biolabs |
Common Stock | Disposition | 2020-11-17 | 40,000 | $5.17 | 1,531,000 | No | 4 | S | Indirect | By Alpha Biolabs |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Alpha Biolabs |
No | 4 | S | Indirect | By Alpha Biolabs |
Footnotes
- Alpha Biolabs is a wholly-owned subsidiary of Alpha Holdings, Inc.